Please Wait
Applying Filters...
menu
    • menu
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    IMIPENEM; CILASTATIN

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,345Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    28/10/2024 Sun Pharmaceutical Industries Limited
    India
    		 SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN R1-CEP 2009-179 - Rev 02 Cilastatin sodium, Sterile 2022-02-21 Valid Chemical 1408
    28/10/2024 Zhuhai United Laboratories Co ., Ltd.
    China
    		 ZHUHAI UNITED LABORATORIES CO., LTD. Sanzao Town CN R1-CEP 2010-184 - Rev 01 Cilastatin sodium, Sterile 2018-10-26 Withdrawn by Holder Chemical 2020-09-09 1408